In addition, we noted that BRAF genetic mutations exhibited mutual exclusivity with TP53 mutations in rectal cancer but significantly cooccurred (p < 0.001) with SMAD4 genetic mutations (p = 0.024). This evidence concerns the gene TP53 and rectal cancer.